1. Report Industry Investment Rating - Not provided in the given content 2. Core Viewpoints of the Report - In March 2026, the manufacturing PMI rebounded beyond expectations, indicating an economic recovery, but the recovery strength is average and the expectations are cautious. Without considering external uncertainties, the prices of domestically - priced commodities are expected to rise. The manufacturing PMI in April 2026 is likely to decline, which is a crucial observation window [4][5][6]. - In March 2026, the non - manufacturing PMI rose, but multiple sub - items are at historically low levels, and the non - manufacturing industry is still in the bottom - building process. The construction industry is still in a downward trend, but the sales price sub - item has bottomed out [29][32]. 3. Summary by Relevant Catalogs Part 1: Review of China's Manufacturing and Non - manufacturing PMI Data Tables - Manufacturing PMI: In March 2026, all sub - items of the manufacturing PMI increased compared to February. The significant increases include the purchase price of main raw materials (up 9 to 63.9), ex - factory price (up 4.8 to 55.4), import (up 4.2 to 49.8), new export orders (up 4.1 to 49.1), and new orders (up 3 to 51.6) [3][4]. - Non - manufacturing PMI: In March 2026, the business activity of non - manufacturing PMI was 50.1, up 0.6 from the previous month. The sub - items with relatively large increases were new export orders, input prices, sales prices, and delivery time. The sub - items with relatively large decreases were domestic demand, inventory, business activity expectations, and employees [3][29]. Part 2: March Manufacturing PMI Reflects Economic Service Beyond Expectations - Manufacturing PMI reached 50.4 in March 2026, up 1.4 from the previous month, higher than the market expectation of 50.1, and above the 50 boom - bust line again after two months. All sub - items increased, indicating an economic recovery. However, some key sub - items are still below 50, and some sub - items are at the second - lowest or lowest levels in the same period since 2018. The economic recovery is influenced by factors such as the arrival of the demand peak season, economic improvement, and price increases due to the Middle East conflict. The recovery strength is average, and expectations are cautious. The prices of domestically - priced commodities are expected to rise. In April 2026, the manufacturing PMI is likely to decline, which is a crucial observation window [4][5][6]. Part 3: Multiple Sub - items of March Non - manufacturing PMI are at Historically Low Levels - In March 2026, the non - manufacturing PMI business activity was 50.1, up 0.6 from the previous month and higher than the expected 49.9, returning above 50 again after two months. The sub - items of non - manufacturing PMI showed mixed trends. The new orders and domestic demand sub - items decreased against the season, indicating that the non - manufacturing industry is still in the bottom - building process. Some sub - items are at the lowest or second - lowest levels in the same period over the years. The construction industry PMI shows a downward trend, but the sales price sub - item has bottomed out, suggesting that the housing price may be stabilizing, but the sustainability needs to be observed [29][32].

Economic Overview - The June economic data reveals five "anomalies," indicating new changes in the economy that may affect the second half of the year [9] - The GDP growth for Q2 was in line with expectations at 5.2%, while retail sales and fixed asset investment showed signs of decline [9] - The construction industry has weakened significantly, impacting overall economic performance [9] Company Analysis: 德源药业 (DeYuan Pharmaceutical) - The company focuses on chronic metabolic diseases and has a robust portfolio of generic drugs, with plans to transition to innovative drug development [12] - Forecasted net profits for 2025-2027 are 192 million, 218 million, and 200 million yuan respectively, with a target market capitalization of 5.6 billion yuan, indicating a potential 42% upside [12] - The company is advancing in innovative drug development, particularly in diabetes and hypertension treatments, with significant market opportunities identified [12] Industry Analysis: Chemical Sector - The chemical industry is experiencing a recovery after price declines, with signs of bottoming out and increased supply disruptions [11][14] - Key sub-sectors such as pesticides, fluorochemicals, and explosives are expected to see profit growth in Q2 2025, driven by improved demand and pricing [11] - The industry is shifting from inventory reduction to capacity reduction, indicating a more stable supply-demand balance moving forward [14] Investment Recommendations - The report suggests a "buy" rating for 德源药业 based on its growth potential and market positioning in the pharmaceutical sector [12] - The chemical sector is rated positively, with a focus on companies that can benefit from the ongoing recovery and supply chain improvements [11][14]

Core Viewpoints - The economic data for June reveals five significant "anomalies," indicating new changes in the economy lurking in hidden corners [3][9][110] - Despite strong performance in exports and industrial production, the second quarter GDP remained in line with expectations due to a notable decline in construction output and price disturbances affecting nominal indicators [3][9][110] Economic Data Overview - In Q2, GDP grew by 5.2%, matching expectations, while June's retail sales increased by 4.8%, below the expected 5.6%. Fixed asset investment rose by 2.8%, also below the anticipated 3.7%, and industrial value added increased by 6.8%, exceeding the expected 5.5% [2][8][107] Consumption Insights - Retail sales and catering revenues saw a significant decline due to the misalignment of e-commerce promotions and competitive subsidies from food delivery platforms. In June, retail sales growth fell by 1.6 percentage points to 4.8%, with notable drops in categories like home appliances and communication equipment [3][20][108] Investment Analysis - Fixed asset investment growth fell to a three-year low, with a 2.7 percentage point drop to 0% in June. This decline is attributed to a decrease in investment prices and significant downturns in construction, manufacturing, and service sector investments [4][23][66] Real Estate Sector - Although real estate financing improved in June, investment remained weak due to the ongoing impact of reduced stock projects. Credit financing for real estate companies rose by 6.8 percentage points to -2.3%, but real estate investment growth fell to -12.9% [4][30][109] Industrial Production - Industrial value added surged due to an increase in working days and "export grabbing." In June, industrial value added rose by 1 percentage point to 6.8%, with specific sectors like textiles and chemical raw materials benefiting from this trend [5][41][54] Long-term Economic Outlook - The "demand front-loading" and "fiscal front-loading" effects may lead to a switch in economic strength between the first and second halves of the year. The economic adjustment phase since 2022 is nearing its end, with expectations for GDP growth around 4.6% in the second half, while the annual target remains at 5.0% [6][46][110]